Cargando…

The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese

BACKGROUND/OBJECTIVE: Apolipoprotein A5 gene promoter region T-1131C polymorphism (APOA5 T-1131C) is known to be associated with elevated plasma TG levels, although little is known of the influence of the interaction between APOA5 T-1131C and lifestyle modification on TG levels. To investigate this...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamasaki, Masayuki, Mutombo, Paulin Beya wa Bitadi, Iwamoto, Mamiko, Nogi, Akiko, Hashimoto, Michio, Nabika, Toru, Shiwaku, Kuninori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Nutrition Society and the Korean Society of Community Nutrition 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523481/
https://www.ncbi.nlm.nih.gov/pubmed/26244076
http://dx.doi.org/10.4162/nrp.2015.9.4.379
_version_ 1782384069912297472
author Yamasaki, Masayuki
Mutombo, Paulin Beya wa Bitadi
Iwamoto, Mamiko
Nogi, Akiko
Hashimoto, Michio
Nabika, Toru
Shiwaku, Kuninori
author_facet Yamasaki, Masayuki
Mutombo, Paulin Beya wa Bitadi
Iwamoto, Mamiko
Nogi, Akiko
Hashimoto, Michio
Nabika, Toru
Shiwaku, Kuninori
author_sort Yamasaki, Masayuki
collection PubMed
description BACKGROUND/OBJECTIVE: Apolipoprotein A5 gene promoter region T-1131C polymorphism (APOA5 T-1131C) is known to be associated with elevated plasma TG levels, although little is known of the influence of the interaction between APOA5 T-1131C and lifestyle modification on TG levels. To investigate this matter, we studied APOA5 T-1131C and plasma TG levels of subjects participating in a three-month lifestyle modification program. SUBJECTS/METHODS: A three-month lifestyle modification program was conducted with 297 participants (Age: 57 ± 8 years) in Izumo City, Japan, from 2001-2007. Changes in energy balance (the difference between energy intake and energy expenditure) and BMI were used to evaluate the participants' responses to the lifestyle modification. RESULTS: Even after adjusting for confounding factors, plasma TG levels were significantly different at baseline among three genotype subgroups: TT, 126 ± 68 mg/dl; TC, 134 ± 74 mg/dl; and CC, 172 ± 101 mg/dl. Lifestyle modification resulted in significant reductions in plasma TG levels in the TT, TC, and CC genotype subgroups: -21.9 ± 61.0 mg/dl, -20.9 ± 51.0 mg/dl, and -42.6 ± 78.5 mg/dl, respectively, with no significant differences between them. In a stepwise regression analysis, age, APOA5 T-1131C, body mass index (BMI), homeostasis model assessment-insulin resistance (HOMA-IR), and the 18:1/18:0 ratio showed independent association with plasma TG levels at baseline. In a general linear model analysis, APOA5 T-1131C C-allele carriers showed significantly greater TG reduction with decreased energy balance than wild type carriers after adjustment for age, gender, and baseline plasma TG levels. CONCLUSIONS: The genetic effects of APOA5 T-1131C independently affected plasma TG levels. However, lifestyle modification was effective in significantly reducing plasma TG levels despite the APOA5 T-1131C genotype background.
format Online
Article
Text
id pubmed-4523481
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher The Korean Nutrition Society and the Korean Society of Community Nutrition
record_format MEDLINE/PubMed
spelling pubmed-45234812015-08-04 The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese Yamasaki, Masayuki Mutombo, Paulin Beya wa Bitadi Iwamoto, Mamiko Nogi, Akiko Hashimoto, Michio Nabika, Toru Shiwaku, Kuninori Nutr Res Pract Original Research BACKGROUND/OBJECTIVE: Apolipoprotein A5 gene promoter region T-1131C polymorphism (APOA5 T-1131C) is known to be associated with elevated plasma TG levels, although little is known of the influence of the interaction between APOA5 T-1131C and lifestyle modification on TG levels. To investigate this matter, we studied APOA5 T-1131C and plasma TG levels of subjects participating in a three-month lifestyle modification program. SUBJECTS/METHODS: A three-month lifestyle modification program was conducted with 297 participants (Age: 57 ± 8 years) in Izumo City, Japan, from 2001-2007. Changes in energy balance (the difference between energy intake and energy expenditure) and BMI were used to evaluate the participants' responses to the lifestyle modification. RESULTS: Even after adjusting for confounding factors, plasma TG levels were significantly different at baseline among three genotype subgroups: TT, 126 ± 68 mg/dl; TC, 134 ± 74 mg/dl; and CC, 172 ± 101 mg/dl. Lifestyle modification resulted in significant reductions in plasma TG levels in the TT, TC, and CC genotype subgroups: -21.9 ± 61.0 mg/dl, -20.9 ± 51.0 mg/dl, and -42.6 ± 78.5 mg/dl, respectively, with no significant differences between them. In a stepwise regression analysis, age, APOA5 T-1131C, body mass index (BMI), homeostasis model assessment-insulin resistance (HOMA-IR), and the 18:1/18:0 ratio showed independent association with plasma TG levels at baseline. In a general linear model analysis, APOA5 T-1131C C-allele carriers showed significantly greater TG reduction with decreased energy balance than wild type carriers after adjustment for age, gender, and baseline plasma TG levels. CONCLUSIONS: The genetic effects of APOA5 T-1131C independently affected plasma TG levels. However, lifestyle modification was effective in significantly reducing plasma TG levels despite the APOA5 T-1131C genotype background. The Korean Nutrition Society and the Korean Society of Community Nutrition 2015-08 2015-06-19 /pmc/articles/PMC4523481/ /pubmed/26244076 http://dx.doi.org/10.4162/nrp.2015.9.4.379 Text en ©2015 The Korean Nutrition Society and the Korean Society of Community Nutrition http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Yamasaki, Masayuki
Mutombo, Paulin Beya wa Bitadi
Iwamoto, Mamiko
Nogi, Akiko
Hashimoto, Michio
Nabika, Toru
Shiwaku, Kuninori
The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese
title The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese
title_full The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese
title_fullStr The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese
title_full_unstemmed The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese
title_short The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese
title_sort interaction of apolipoprotein a5 gene promoter region t-1131c polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in japanese
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523481/
https://www.ncbi.nlm.nih.gov/pubmed/26244076
http://dx.doi.org/10.4162/nrp.2015.9.4.379
work_keys_str_mv AT yamasakimasayuki theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT mutombopaulinbeyawabitadi theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT iwamotomamiko theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT nogiakiko theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT hashimotomichio theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT nabikatoru theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT shiwakukuninori theinteractionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT yamasakimasayuki interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT mutombopaulinbeyawabitadi interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT iwamotomamiko interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT nogiakiko interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT hashimotomichio interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT nabikatoru interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese
AT shiwakukuninori interactionofapolipoproteina5genepromoterregiont1131cpolymorphismrs12286037andlifestylemodificationonplasmatriglyceridelevelsinjapanese